Stay updated with breaking news from Generate Returns. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Addressing the current talent shortage is a delicate balancing act—reliant on innovative approaches, workforce diversity, and training workers in relevant skills.
Why Investors Should Buy Moderna Stock InvestorPlace 12/18/2020 Moderna (NASDAQ: MRNA) has arguably priced in the medium-term proceeds from its vaccine for the novel coronavirus. But Moderna stock does not yet appear to reflect the potential of its other vaccines under development, the promising drugs it can acquire in the future, or its own status as a potential takeover target. © Provided by InvestorPlace The Moderna (MRNA) logo surrounded by syringes, pills and disposable face masks. Of course Moderna’s vaccine, MRNA-1273, recently won emergency-use approval (EUA) from the FDA. More...